When bleeding complicates oral anticoagulant therapy

Preview

The risk-benefit ratio of oral anticoagulant therapy is of special concern in the 1990s, because potential uses of these agents are expanding rapidly. A careful review of all aspects of therapy with patients new to anticoagulants may improve compliance and lessen the incidence of bleeding, the major complication. Dr Brigden provides case reports to illustrate risk factors for bleeding, approaches to determining the source, and management of elevated prothrombin time.

Additional information

Notes on contributors

Malcolm L. Brigden

Malcolm L. Brigden, MD Dr Brigden is director of hematology, Metro-McNair Clinical Laboratories, and consultant in hematology-oncology at Victoria General and Royal Jubilee hospitals, Victoria, British Columbia.